News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Richard Hughes IV

home / authors / richard-hughes-iv

Partner at Epstein Becker Green

Articles


Spreeha Choudhury Richard Choudhury

Don’t Fall for the Call of Placebo-Controlled Vaccine Trials

Spreeha Choudhury;Richard Hughes IV
June 25th 2025

The idea of denying people proven medicines in the name of research has a dark legacy in this country.


Congress, Have a More Thoughtful, Bipartisan Pandemic Post-Mortem

Congress, Have a More Thoughtful, Bipartisan Pandemic Post-Mortem

Richard Hughes IV
July 15th 2024

Congress and our nation’s public health officials should take the current moment to self-reflect and resolve challenges with public confidence in our public and scientific institutions.

Latest Updated Articles

Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: June 19th 2024 | Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Stock.adobe.com
Published: July 25th 2025 | Updated: August 3rd 2025
Replimune CRL Fallout: How Biopharma Leaders Should Manage a New Layer of FDA Uncertainty
Emrelis and the Evolving Landscape of Antibody Drug Conjugates
Published: July 21st 2025 | Updated: August 3rd 2025
Emrelis and the Evolving Landscape of Antibody Drug Conjugates
Emrelis Approval Highlights FDA Confidence in ADC Oncology Treatments
Published: July 22nd 2025 | Updated: August 3rd 2025
Emrelis Approval Highlights FDA Confidence in ADC Oncology Treatments
Tommy Bramley, SVP of Global Consulting Services at Cencora.
Published: July 8th 2025 | Updated: August 3rd 2025
Advancing Innovation in Cancer Care: Bringing the Next Wave of Oncology Products to Market
Jennifer Kyle
Published: June 24th 2025 | Updated: August 3rd 2025
Developing FP&A Strategies in Today’s Environment: Q&A with Jennifer Kyle
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.